Project Grant HT94252410443
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$377K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
The Medical University of South Carolina (MUSC) was awarded a $792,245 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LEVERAGING LINEAGE ADDICTION: NUCLEAR DELIVERY OF THERAPEUTIC TRANSGENES RESPONSIVE TO ONCOGENIC TRANSCRIPTION FACTOR OVEREXPRESSION," will fund research focused on developing innovative gene therapy approaches to treat various medical conditions. The award has a performance...
The Medical University of South Carolina (MUSC) was awarded a $755,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 15, 2024, will support MUSC's research on the role of oxidative stress in heavy metal exposure-induced Alzheimer's disease. This project aims to investigate the link between environmental toxin exposure and the development of neurodegenerative disorders, with a focus on gaining a...
The Defense Health Agency awarded a $755,001 Project Grant to The Medical University of South Carolina (MUSC) under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, running from July 1, 2023 to June 30, 2026, supports research on microsomal glutathione transferase as a new target in melanotic melanoma. As a public institution of higher education, MUSC conducts biomedical research and provides healthcare services, with a mission to preserve and optimize...
The Medical University of South Carolina (MUSC) was awarded a $1,503,880 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research into the function of the ARIH1 gene in epithelial-mesenchymal transition (EMT) and tumorigenesis. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative...
The Department of Defense's (DoD) Military Medical Research and Development program (CFDA 12.420) awarded a $1,009,369 project grant to Brigham & Women's Hospital in Boston, MA. The grant funds a 3-year research project titled "Probing the Role of Ion Channels as Mediators of Post-Traumatic Epileptogenesis: GIRK Channel Modulation as a Roadmap to Therapy." The research aims to: 1) characterize aberrant neuronal activity patterns in the brain following traumatic brain injury...
The U.S. Department of Defense, Defense Health Agency has awarded a $918,000 Project Grant to the Texas A&M University System Health Science Center to conduct research on "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". This 3-year grant, running from September 15, 2024 to September 14, 2027, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate basic and translational research on the role...
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...
The University of Southern California (USC) received a $828,538 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "MICRORNA THERAPY TARGETING FIBROTIC SCAR FORMATION FOR IMPROVEMENT OF COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY". The award has a performance period from May 1, 2024 to April 30, 2027. The funded research aims to develop novel microRNA-based therapies to address fibrotic...
The University of Cincinnati Sponsored Research Services Division was awarded an $817,296 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research on spreading depolarizations as a predictive biomarker of post-traumatic epilepsy from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research...
The federal Project Grant award titled "PSYCHIATRIC ASPECTS OF POST-TRAUMATIC EPILEPSY" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $650,000 award will fund biomedical research at The Trustees of Columbia University in the City of New York, Health Sciences Division over a 3-year period from Apr 2025 to Apr 2028. The research aims to investigate innovative medical solutions and transform healthcare for military...